Call: (+91) 73979 11126
Name : Fildena Double Composition : Sildenafil Strength : 200mg Manufactured by : Fortune Healthcare Pvt. Ltd. Form : Tablet Packing : 10×10 Tablets
Fildena Double Tablet is one of the high performance ED products known for their quick action and long lasting results. It is a medication which is utilized to treat erectile dysfunction in men by managing the blood stream in pelvic organs so that sexual coexistence can be appreciated with full delight.
The working method of Fildena double 200 mg kicks off with the inhibition of the PDE-5 hormones once generic Sildenafil becomes active. This is then able to start the actions of the cGMP hormone on your body.
Meanwhile, nitric oxide can trigger itself and cause the vasodilation action on arteries to begin. By vasodilation, the arterial walls can relax and this is what triggers more blood flow.
As the blood flow increases through the penis tissues you can easily sense the hardness on your erections by stimulating it manually.
As such, there is one and only one use of Fildena double 200 mg. This is to bring you the required hardness during having sex and to enable and bring back your penetration capabilities.
But since the dose is very heavy and generally double the standard which is taken to be 100 mg you need to take it with caution.
Make sure that no side effects are cropping up. Doctors generally recommend that they don’t take the Fildena double 200 mg right from the start.
If you have not taken any generic Sildenafil PDE-5 hormone inhibiting pill ever in your life it would be rather better if you start with a lower dose and then go higher up until you have found the right dose to bring the required hardness.
Product Enquiry
Select you countryAfghanistanAlbaniaAlgeriaAndorraAngolaAntigua and BarbudaArgentinaArmeniaAustraliaAustriaAzerbaijanThe BahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBruneiBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCentral African RepublicChadChileChinaColombiaComorosCongoCosta RicaCroatiaCubaCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFijiFinlandFranceGabonThe GambiaGeorgiaGermanyGhanaGreeceGrenadaGuatemalaGuineaGuinea-BissauGuyanaHaitiHondurasHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyamaicaJapanJordanKazakhstanKenyaKiribatiKorea, NorthKorea, SouthKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMauritaniaMauritiusMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew ZealandNicaraguaNigerNigeriaNorth MacedoniaNorwayOmanPakistanPalauPanamaPapua New GuineaParaguayPeruPhilippinesPolandPortugalQatarRomaniaRussiaRwandaSaint Kitts and NevisSaint LuciaSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSpainSri LankaSudanSudan, SouthSurinameSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamYemenZambiaZimbabwe
Log in